Elastin-derived peptide hydrogels for sustained dermal delivery of tetrapeptide-21
File(s)1-s2.0-S0378517325013274-main.pdf (6.73 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Tetrapeptide-21 (GEKG) has demonstrated anti-aging efficacy. This work emphasises the need for advanced delivery systems beyond conventional topicals and highlights elastin-derived peptides (EDPs) as promising hydrogel-forming carriers due to their self-assembly, crosslinking ability, and sustained bioactive peptide release. First- and second-generation EDPs were designed, synthesised and evaluated for their ability to encapsulate drug molecules. Using the collagen-stimulating tetrapeptide-21 (a bioactive peptide that promotes tissue repair), we assessed their encapsulation and permeation properties. Transmission electron microscopy (TEM) revealed uniform nanofibres with a hollow structure, suggesting their potential for molecular scaffolding and sustained drug delivery. Both peptide generations sustained skin permeation of tetrapeptide-21, achieving permeation rates of 7.5 % to 20.9 % over 72 h, compared to 26.6 % for the free drug solution. The second-generation exhibited superior matrix-forming ability, which led to slower skin permeation. This is attributable to the reduced positive charge in the second-generation hydrogels, which enhanced their physical robustness. Given their tuneable release profiles, these hydrogels hold potential not only for cosmetic applications but also for therapeutic uses.
Date Issued
2026-01-20
Date Acceptance
2025-12-10
Citation
International Journal of Pharmaceutics, 2026, 689
ISSN
0378-5173
Publisher
Elsevier BV
Journal / Book Title
International Journal of Pharmaceutics
Volume
689
Copyright Statement
© 2025 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
License URL
Publication Status
Published
Article Number
126490
Date Publish Online
2025-12-18